Glipizide Tablet, Extended Release
Product Images NDC 70518-3896

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 70518-3896). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Glipizide 10 mg Extended-Release oral tablet label for a 30-tablet quantity. The label includes the product name, strength, dosage form, and quantity. It shows the labeler as RemedyRepack Inc., with a manufacturer name Northstar Rx LLC in Memphis, TN. Additional details include the NDC number 70518-3896-00, storage instructions, and a barcode with a QR code.*

FDA Label Image

Glipezide Usp (C65265e1 A7eb 43ea 890a 00a227570956 01)

Chemical structure of Glipizide, showing the molecular arrangement including a methyl-substituted pyridine ring, sulfonylurea functional group, and cyclohexyl moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.